INVICTUS MD Strategies CORP. (TSXV:GENE OTC:IVITF FRA:8IS1) (“Invictus” or the “Company”) is delighted to announce the appointment of Harbir Toor as Main Fiscal Officer (“CFO”) on March seven, 2019, to realize success Dylan Easterbrook. 

INVICTUS MD Procedures CORP. (TSXV:GENE OTC:IVITF FRA:8IS1) (“Invictus” or the “Company”) is joyful to announce the appointment of Harbir Toor as Chief Fiscal Officer (“CFO”) on March 7, 2019, to be successful Dylan Easterbrook.

Ms. Toor provides to Invictus virtually 20 several years of financial administration skills in every private and non-private corporations, jointly with large-advancement and startup phase businesses. Ms. Toor most not too very long ago served as Vice President, Finance of a non-public, health-related stage biopharmaceutical company and executed a vital functionality in a quantity of fairness and personal debt financings, alongside one another with a US$25 million fairness funding. Prior to that, Ms. Toor held a lot of senior finance positions alongside one another with Interim Finance Director of a not-for-financial gain team and Corporate Controller of a community pharmaceutical business. In her roles, Ms. Toor excelled in strategy execution, shareholder worthy of generation, and menace administration. Ms. Toor started out her job with KPMG doing audit, tax and accounting perform for major buyers. Ms. Toor is a Chartered Experienced Accountant (CPA, CA) and retains a Bachelor in Business enterprise Administration diploma from Simon Fraser University in Canada.

“With Ms. Toor onboard, we have made a powerful addition to our go-ahead leadership staff. Her encounter with NASDAQ and Toronto Stock Trade corporations will serve Invictus well as we pursue the next stage of our expansion technique,” mentioned George E. Kveton, President and CEO of Invictus. “On behalf of the workforce at Invictus, I want to thank Dylan for his substantial contribution and dedication to the Firm, and for making certain a sleek changeover.”

For added data, make sure you go to

On Behalf of the Board,
George E. Kveton
Chief Executive Officer and Director

Jessica Martin
Vice President, Public Relations and Regulatory Affairs
(833) 879-4363

About Invictus

Invictus is a globe cannabis business supplying a assortment of merchandise under a variety of brands. Our built-in route-to-client system is outlined by 5 pillars of gross profits and distribution together with health-related, grownup-use leisure, retail, Licensed Producer to Accredited Producer and globally.

Invictus has partnered with enterprise leaders to express our company imaginative and prescient, alongside one another with KISS songs legend and business mogul Gene Simmons as our Chief Evangelist Officer. To fulfill soaring desire, Invictus is growing its cultivation footprint, with three hashish producing facilities licensed under the Hashish Act and Cannabis Laws in Canada. To accommodate home and around the globe gross income, Invictus’ wholly-owned subsidiary, Acreage Pharms Ltd., is properly remarkable in setting up its Stage 3 function-developed cultivation facility to be European Union Fantastic Production Tactics compliant. The Business is concentrating on for as a great deal as fifty p.c of its producing to comprise medical hashish. To assurance consistency in significant high quality and supply, Invictus participates in all aspects of the growing course of by its subsidiary, Long term Harvest Progress Ltd., a significant-high quality fertilizer and vitamins producer. Invictus drives sustainable long-phrase shareholder worth by a diversified products portfolio with above 70 Wellness Canada accredited strains and a multifaceted distribution method alongside one another with health care, adult-use, all over the world, Accredited Producer to Certified Producer and retail retailers. For more facts go to

Neither the TSX Enterprise Exchange nor its Regulation Expert services Service provider accepts responsibility for the adequacy or accuracy of this launch.

Click right here to link with Invictus (TSXV:GENE, OTC:IVITF) for an Investor Presentation.

Source link


Please enter your comment!
Please enter your name here